Document is current
Any future updates will be listed below
-
Authors
Walters, Katherine F.
Templeton, John M.
van Loveren, Harry
Yusuf, Fayyadh R.
Schilaty, Nathan D. https://orcid.org/0000-0002-6038-7126
- License Information
-
More Information
Article History
Received: 24 October 2025
Accepted: 30 January 2026
First Online: 16 February 2026
Declarations
:
: This sub-study was approved by the Institutional Review Board (IRB) at the University of South Florida (IRB# 6819). Written, informed consent will be obtained from all participants prior to study participation. The United States Food and Drug Administration (FDA) has authorized the use of hyperbaric oxygen therapy (HBOT) under an Investigational New Drug (IND)/Investigational Device Exemption (IDE; IND/IDE #: 172640).
: Not applicable.
: All authors declare no competing interests.
